Literature DB >> 15162240

Optimal management of the morbidly obese patient. SAGES appropriateness conference statement.

D B Jones1, D A Provost, E J DeMaria, C D Smith, L Morgenstern, B Schirmer.   

Abstract

BACKGROUND: Obesity is a growing health problem that contributes to numerous life-threatening or disabling disorders, including coronary artery disease, hypertension, type 2 diabetes mellitus, hyperlipidemia, degenerative joint disease, and obstructive sleep apnea. Significant weight reduction in the morbidly obese improves or reverses associated illness and benefits well-being. The purpose of the SAGES Appropriateness Conference was to summarize the state of the art for open and laparoscopic operations for the morbidly obese.
METHODS: The English literature comparing bariatric procedures was reviewed and grouped by level of evidence by three surgeons (BS, LV, and CC). From more than 1,500 articles, all conference participants were provided with reprints and table summaries of no less than 50 selected manuscripts. Ten experts were requested to present reviews and make evidence-based arguments for and against the open and laparoscopic approaches in written format. An expert panel of six surgeons, including an ethicist and patient, commented on implications of data presented. The finalized statement was e-mailed to all participants for approval and comment.
RESULTS: Consensus statements were achieved on various aspects of morbid obesity, including indications for surgery, resolution of comorbid illnesses with significant weight loss, and the importance of committed bariatric program. Our panel of experts agreed, in general, to the advantages of laparoscopic approaches compared to open operations in skilled hands.
CONCLUSIONS: Laparoscopic Roux-en-Y gastric bypass (RYGB) affords improved short-term recovery compared to open gastric bypass. Laparoscopic adjustable banding can be performed with lower average mortality than either RYGB or any of the malabsorptive operations, and it produces variable degrees of short-term weight loss. Prospective randomized trials are needed to compare gastric bypass, malabsorptive, and restrictive procedures.

Entities:  

Mesh:

Year:  2004        PMID: 15162240     DOI: 10.1007/s00464-004-8132-6

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  40 in total

1.  Surgery for Obesity- An Update of a Randomized Trial.

Authors: 
Journal:  Obes Surg       Date:  1995-05       Impact factor: 4.129

2.  Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement.

Authors: 
Journal:  Am J Clin Nutr       Date:  1992-02       Impact factor: 7.045

3.  Duodenal switch: an effective therapy for morbid obesity--intermediate results.

Authors:  A Baltasar; R Bou; M Bengochea; F Arlandis; C Escrivá; J Miró; R Martínez; N Pérez
Journal:  Obes Surg       Date:  2001-02       Impact factor: 4.129

4.  Twenty-four-hour energy and nutrient balance in weight stable postobese patients after biliopancreatic diversion.

Authors:  P A Tataranni; G Mingrone; C A Raguso; A De Gaetano; R M Tacchino; M Castagneto; A V Greco
Journal:  Nutrition       Date:  1996-04       Impact factor: 4.008

5.  Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up.

Authors:  A C Wittgrove; G W Clark
Journal:  Obes Surg       Date:  2000-06       Impact factor: 4.129

6.  Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesity.

Authors:  P E O'Brien; W A Brown; A Smith; P J McMurrick; M Stephens
Journal:  Br J Surg       Date:  1999-01       Impact factor: 6.939

7.  Biliopancreatic diversion.

Authors:  N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

8.  Prospective investigation of complications, reoperations, and sustained weight loss with an adjustable gastric banding device for treatment of morbid obesity.

Authors:  C Doherty; J W Maher; D S Heitshusen
Journal:  J Gastrointest Surg       Date:  1998 Jan-Feb       Impact factor: 3.452

9.  A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters.

Authors:  H J Sugerman; J V Starkey; R Birkenhauer
Journal:  Ann Surg       Date:  1987-06       Impact factor: 12.969

10.  The effectiveness of gastric bypass over gastric partition in morbid obesity: consequence of distal gastric and duodenal exclusion.

Authors:  W J Pories; E G Flickinger; D Meelheim; A M Van Rij; F T Thomas
Journal:  Ann Surg       Date:  1982-10       Impact factor: 12.969

View more
  16 in total

Review 1.  Is type 2 diabetes a surgical disease?

Authors:  Mehran Anvari
Journal:  Can J Surg       Date:  2007-08       Impact factor: 2.089

Review 2.  Laparoscopic bariatric surgery.

Authors:  B Schirmer
Journal:  Surg Endosc       Date:  2006-03-16       Impact factor: 4.584

3.  Bariatric surgery training: getting your ticket punched.

Authors:  Bruce D Schirmer; Philip R Schauer; David R Flum; James Ellsmere; Daniel B Jones
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

4.  Interdisciplinary European guidelines for surgery for severe (morbid) obesity.

Authors:  Martin Fried; Vojtech Hainer; Arnaud Basdevant; Henry Buchwald; Mervyn Deitel; Nicholas Finer; Jan Willem M Greve; Fritz Horber; Elisabeth Mathus-Vliegen; Nicola Scopinaro; Rudolf Steffen; Constantine Tsigos; Rudolf Weiner; Kurt Widhalm
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

5.  Interdisciplinary European guidelines on metabolic and bariatric surgery.

Authors:  M Fried; V Yumuk; J M Oppert; N Scopinaro; A Torres; R Weiner; Y Yashkov; G Frühbeck
Journal:  Obes Surg       Date:  2014-01       Impact factor: 4.129

6.  Laparoscopic gastric bypass performed with the Da Vinci Intuitive Robotic System: preliminary experience.

Authors:  U Parini; M Fabozzi; R Brachet Contul; P Millo; A Loffredo; R Allieta; M Nardi; E Lale-Murix
Journal:  Surg Endosc       Date:  2006-12       Impact factor: 4.584

7.  Revisional vs. primary Roux-en-Y gastric bypass--a case-matched analysis: less weight loss in revisions.

Authors:  Urs Zingg; Alexander McQuinn; Dennis DiValentino; Steven Kinsey-Trotman; Philip Game; David Watson
Journal:  Obes Surg       Date:  2010-12       Impact factor: 4.129

8.  Benchmarking hospital outcomes for laparoscopic adjustable gastric banding.

Authors:  M A Edwards; R Grinbaum; B E Schneider; A Walsh; J Ellsmere; D B Jones
Journal:  Surg Endosc       Date:  2007-05-05       Impact factor: 4.584

9.  Three-year follow-up study of retrocolic versus antecolic laparoscopic Roux-en-Y gastric bypass.

Authors:  Markus K Müller; Josef Guber; Stefan Wildi; Ivo Guber; Pierre-Alain Clavien; Markus Weber
Journal:  Obes Surg       Date:  2007-07       Impact factor: 4.129

10.  Prospective evaluation of laparoscopic Roux en Y gastric bypass in patients with clinically severe obesity.

Authors:  Konstantinos Vagenas; Spyros Panagiotopoulos; Ioannis Kehagias; Stavros-Nikolaos Karamanakos; Nancy Mead; Fotis Kalfarentzos
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.